SCHEMBL379444

SCHEMBL379444

CCCCCCCCOc1ccc(-c2nc(-c3ccc(C(C)(C)C)cc3C(C)(C)C)nc(-c3ccc(C(C)(C)C)cc3C(C)(C)C)n2)c(O)c1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NR5A1 Q13285 1/20 0.45
PTPN11 Q06124 3/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CNR2 P34972 2/20 0.40
PDK2 Q15119 2/20 0.40
LTA4H P09960 1/20 0.40
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29351856 1.00 NR5A1 (0.45) NR5A1PTPN11MEN1NPC1ALDH1A1
SCHEMBL6681432 0.87 PTPN11 (0.46) NR5A1PTPN11MEN1NPC1ALDH1A1
SCHEMBL5546811 0.87 PTPN11 (0.46) NR5A1PTPN11MEN1NPC1ALDH1A1
SCHEMBL28319325 0.86 THRB (0.39) PTPN11NPC1CNR2
SCHEMBL29364526 0.85 NR5A1 (0.60) NR5A1PTPN11MEN1NPC1ALDH1A1
SCHEMBL29502795 0.85 NR5A1 (0.60) NR5A1PTPN11MEN1NPC1ALDH1A1
SCHEMBL999167 0.85 NR5A1 (0.60) NR5A1PTPN11MEN1NPC1ALDH1A1
SCHEMBL77484 0.85 NR5A1 (0.60) NR5A1PTPN11MEN1NPC1ALDH1A1
SCHEMBL7972017 0.85 NR5A1 (0.60) NR5A1PTPN11MEN1NPC1ALDH1A1
SCHEMBL29502758 0.85 NR5A1 (0.60) NR5A1PTPN11MEN1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof ADEKA CORPORATION (JP) 2026-05-12 US disclosed
US-20260125314-A1 TRANSPARENT LAMINATE NIPPON SHEET GLASS COMPANY, LIMITED (JP) 2026-05-07 US disclosed
EP-4726011-A1 FLAME RETARDANT, COMPOSITION, AND MOLDED ARTICLE ADEKA CORPORATION (JP) 2026-04-15 EP disclosed
US-20260092163-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION, AND MOLDED PRODUCT ADEKA CORPORATION (JP) 2026-04-02 US disclosed
US-12540122-B2 Nucleating agent, synthetic-resin composition containing same, and molded object thereof ADEKA CORPORATION (JP) 2026-02-03 US disclosed
US-12540229-B2 Flame-retardant composition and flame-retardant synthetic resin composition ADEKA CORPORATION (JP) 2026-02-03 US disclosed
US-12528733-B2 Transparent laminate NIPPON SHEET GLASS COMPANY, LIMITED (JP) 2026-01-20 US disclosed
EP-4678699-A1 RESIN ADDITIVE, COMPOSITION, MOLDED ARTICLE AND COMPOUND ADEKA CORPORATION (JP) 2026-01-14 EP disclosed
EP-4640753-A2 NUCLEATING AGENT, SYNTHETIC-RESIN COMPOSITION CONTAINING SAME, AND MOLDED OBJECT THEREOF ADEKA CORPORATION (JP) 2025-10-29 EP disclosed
EP-4632041-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION AND MOLDED ARTICLE ADEKA CORPORATION (JP) 2025-10-15 EP disclosed
EP-1277794-B1 Flame-retardant resin composition ASAHI DENKA KOGYO KK (JP) 2005-04-06 EP disclosed
EP-1516907-A1 FLAME RETARDER COMPOSITION AND FLAME RETARDANT RESIN COMPOSITION CONTAINING THE COMPOSITION Asahi Denka Co., Ltd. (JP) 2005-03-23 EP disclosed
US-20040122137-A1 Ultraviolet absorber composition and resin composition stabilized with the composition ADEKA CORPORATION (JP) 2004-06-24 US disclosed
EP-1405887-A1 ULTRAVIOLET ABSORBER COMPOSITION AND RESIN COMPOSITION STABILIZED WITH THE COMPOSITION Asahi Denka Kogyo K. K. (JP) 2004-04-07 EP disclosed
US-20030088000-A1 Flame-retardant resin composition ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2003-05-08 US disclosed
US-6555603-B1 Addition of a nitroxy compound to a low density polymer ASAHI DENKA KOGYO K.K. (JP) 2003-04-29 US disclosed
EP-1277794-A1 Flame-retardant resin composition ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2003-01-22 EP disclosed
EP-1209190-A1 NUCLEATING AGENT ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2002-05-29 EP disclosed
EP-1156083-A1 RESIN COMPOSITION FOR AGRICULTURAL FILM ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 2001-11-21 EP disclosed
US-6103828-A A BLENDS COMPRISING THERMOPLASTIC RESINS, THERMOSETTING RESINS AND RUBBERS, AND A POLYVINYL CYCLOHEXANE RESIN OR ACOMPOUND HAVING HYDROINDANE AS VISCOSITY MODIFIER; IMPROVES MELT FLOW, FLEXIBILITY AT A LOW TEMPERATURE, BENDING STRENGTH HITACHI CHEMICAL CO. LTD. (JP) 2000-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125314-A1 TRANSPARENT LAMINATE EPCAM, L1CAM, ICAM1 NR5A1 2407/4885PTPN11 2354/4885MEN1 2971/4885
US-12540122-B2 Nucleating agent, synthetic-resin composition containing same, and molded object thereof NXF1, NAP1L1, POT1 NR5A1 543/4885PTPN11 2871/4885MEN1 2216/4885
US-12528733-B2 Transparent laminate DSG1, RRP15, RO60 NR5A1 1726/4885PTPN11 2203/4885MEN1 4375/4885
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof SORD, SUCLA2, SUCLG1 NR5A1 1073/4885PTPN11 4041/4885MEN1 2208/4885
US-12540229-B2 Flame-retardant composition and flame-retardant synthetic resin composition PAF1, RER1, POLR2A NR5A1 2121/4885PTPN11 2214/4885MEN1 3134/4885
US-20260092163-A1 FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION, AND MOLDED PRODUCT PHOSPHO1, PAF1, PPA1 NR5A1 1527/4885PTPN11 1757/4885MEN1 1555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.